发明名称 Ovulation inhibitors contg spironolactone - with reduced side effects
摘要 <p>Spironolactone (I) is added to ovulation inhibitors (oestrogen + gestagen) as a specific antagonist for the undesirable side effects of the gestagen, i.e. Na build-up in the body accompanied by oedema and hypertension. The ovulation inhibitor may be monophasic or biphasic, and each dosage unit pref. contains 10-15 mg. (I).</p>
申请公布号 DE2061698(A1) 申请公布日期 1972.07.06
申请号 DE19702061698 申请日期 1970.12.15
申请人 发明人
分类号 A61K31/585 主分类号 A61K31/585
代理机构 代理人
主权项
地址